Jason Douglas Wilson, Chief Financial Officer at REATA PHARMACEUTICALS INC (RETA), sold 28,296 shares at $93.18 ($2.6M) on 2019-03-19, disclosed to the SEC on 2019-03-21.
Open-market sale of $2.6M RETA by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $93.18 | 19,947 | $1.9M | 70.3% |
| 2 | $94.16 | 7,249 | $683K | 25.8% |
| 3 | $95.01 | 1,100 | $105K | 4.0% |
| Total | $93.50 avg | 28,296 | $2.6M | 100% |
| Filing → |
| RETA | SELL | 2019-10-21 | $1.7M | — | Filing → |
| RETA | SELL | 2019-10-15 | $5.5M | — | Filing → |
| RETA | SELL | 2019-10-15 | $2.1M | — | Filing → |